Cited by 183Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesChild and Adolescent Psychosocial and Emotional DevelopmentTreatment of Major Depression

EFFICACY AND TOLERABILITY OF ANTIDEPRESSANTS IN PEDIATRIC ANXIETY DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS: Research Article: Pediatric Anxiety Meta-Analysis

Open access
Strawn, Jeffrey R., Welge, Jeffrey A., Wehry, Anna M., Keeshin, Brooks, Rynn, Moira A.·2015·Depression and Anxiety

Abstract

BACKGROUND: Randomized controlled trials have demonstrated that antidepressants are efficacious in the treatment of anxiety disorders in youth. However, there are no recent, systematic analyses of the efficacy, safety, or tolerability of these medications in pediatric anxiety disorders. METHODS: A systematic review and meta-analysis of prospective, randomized, parallel-group, controlled trials of selective serotonin reuptake inhibitors (SSRIs) and selective serotonin-norepinephrine reuptake inhibitors (SSNRIs) in pediatric patients with non-obsessive compulsive disorder (OCD) anxiety disorders was undertaken using a search of PubMed/Medline (1966-2014). The meta-analysis utilized random-effects models to evaluate change in the Pediatric Anxiety Rating Scale or similar anxiety scale, suicidality, and adverse events. Additionally, pharmacologic variables were explored with regard to effect size, although no correction for multiple comparisons was made with regard to these relationships. RESULTS: Nine trials involving 1,673 patients and six medications were included. All SSRI/SSNRIs evaluated demonstrated efficacy, and the meta-analytic estimate of effect was of moderate magnitude (Cohen's d = 0.62, confidence interval [CI]: 0.34-0.89, P = .009) and there was evidence of modest heterogeneity (I(2) = 0.29, P = .103). Activation trended toward being more likely with antidepressant treatment (OR: 1.86, CI: 0.98-3.53, P = .054), but no increased risk was observed for nausea/abdominal symptoms (P = .262), discontinuation as a result of an adverse event (P = .132), or suicidality (OR: 1.3, CI: 0.53-3.2, P = .514). Finally, the effect size correlated with the serotonergic specificity of the agent (R = .79, P = .021). CONCLUSIONS: Data for nine SSRI/SSNRIs suggest superiority of antidepressants relative to placebo for the treatment of pediatric anxiety disorders with a moderate effect size.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/da.22329

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The adverse effect profiles of antidepressant medications are well known, and any potential adverse events from psychological therapies remain underinvestigated.

    “However, the adverse effect profiles of antidepressant medications are well known (Strawn 2015;Wang 2017), and any potential adverse events from psychological therapies remain underinvestigated.”

    From Exercise for the treatment of anxiety in children and adolescents (2022) · cites this paper as Strawn 2015

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Strawn, J. R., Welge, J. A., Wehry, A. M., Keeshin, B., & Rynn, M. A.
Affiliations
  • Cincinnati Children's Hospital Medical Center (US)
  • University of Cincinnati (US)
  • University of Utah (US)
  • New York State Psychiatric Institute (US)
Corresponding author
Strawn, Jeffrey R.
Venue
Depression and Anxiety
Publisher
Wiley
Published
2014-11-28
Volume
32
Issue
3
Pages
149-157
ISSN
1091-4269 (ISSN-L)
OpenAlex
W2125405058
Cited by
183
References
48
Citations by year
2026: 8 · 2025: 10 · 2024: 17 · 2023: 17 · 2022: 10 · 2021: 15 · 2020: 15 · 2019: 17 · 2018: 22 · 2017: 24 · 2016: 21 · 2015: 6
FWCI
2.30
Type
journal article
Language
en
Open access
Locations
  • Depression and Anxiety (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Mental Health (MH106037)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
antidepressants, childhood anxiety disorders, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, treatment efficacy, tolerability, adverse events, suicidality, placebo comparison
MeSH terms
Serotonin and Noradrenaline Reuptake Inhibitors, Adolescent, Antidepressive Agents, Anxiety, Anxiety Disorders, Child, Humans, Prospective Studies, Psychiatric Status Rating Scales, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors, Suicidal Ideation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review